A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection
Clinical trial NCT03980314 · COMPLETED
Trial details
- NCT number
- NCT03980314
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-24
- Primary completion
- 2021-03-04
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.